| 生物活性 |
Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer.
|
|---|---|
| 分子量 |
144.56 kDa
|
| CAS号 |
1365287-97-3
|
| 中文名称 |
Emibetuzumab
|
| 运输条件 |
Shipping with dry ice.
|
| 储存方式 |
Store at -20˚C
|
纯度： ≥95%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet